FDA Approved: CALCIUM ACETATE — Original Application (Chartwell RX LLC)

View source ↗

Summary

FDA approves Chartwell RX LLC's calcium acetate as a new generic phosphate binder under an Original Application (ANDA 202420).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• Calcium Acetate (Calcium Acetate)

Snippet

ORIG AP for CALCIUM ACETATE (CALCIUM ACETATE)